Journal of the American Society of Echocardiography
Volume 22, Issue 11 , Pages 1249-1255, November 2009

Microvascular Function in Takotsubo Cardiomyopathy With Contrast Echocardiography: Prospective Evaluation and Review of Literature

Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota

published online 22 September 2009.

Background

Takotsubo cardiomyopathy (TC) mimics ST-elevation myocardial infarction without substantial angiographic stenosis. Coronary microvascular dysfunction has been proposed as a possible mechanism in TC. The aim of this study was to evaluate microvascular function in TC using real-time myocardial contrast echocardiography (MCE).

Methods

Real-time MCE was performed within 24 hours of coronary angiographic diagnosis of TC. Myocardial perfusion was evaluated through qualitative and quantitative myocardial contrast echocardiographic analyses comparing normal segments with segments with dysfunctional wall motion (WM).

Results

From January 2007 to January 2008, 11 patients received diagnoses of TC. Of these patients, 9 were prospectively enrolled (mean age, 70.9 ± 17.5 years; 8 women). Qualitative and quantitative myocardial contrast echocardiographic analyses were feasible in 87% and 81% of segments. Overall, concordance between qualitative MCE and WM for normal versus abnormal analysis was observed in 71% of segments (κ = 0.442, SE = 0.08). Significantly lower myocardial blood flow velocity (β) and lower myocardial blood flow (Aβ) were detected in segments with dysfunctional WM compared with those with normal WM (β = 0.55 ± 0.39 vs 0.90 ± 0.77, P = .009; Aβ = 5.31 ± 3.92 vs 12.38 ± 13.47, P = .002). In the discordant segments between qualitative MCE and WM, the quantitative perfusion parameters β and Aβ were significantly lower in segments with dysfunctional WM compared with those with normal WM (β = 0.22 ± 0.20 vs 1.79 ± 0.57, P = .01; Aβ = 1.90 ± 1.1 vs 24.29 ± 19.9, P = .02). Recovery of WM abnormalities was detected in all patients during follow-up echocardiography (mean, 60.3 ± 66.0 days). No contrast-related side effects were reported. During mean follow-up of 5.9 ± 4.6 months, there were no cardiac events, but 1 noncardiac death (from lung cancer) occurred.

Conclusion

TC is associated with abnormal myocardial perfusion detected with qualitative and quantitative MCE, indicative of microvascular dysfunction.

Keywords: Cardiomyopathy, Contrast echocardiography, Coronary artery disease, Myocardial infarction

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0894-7317(09)00675-0

doi:10.1016/j.echo.2009.07.012

Journal of the American Society of Echocardiography
Volume 22, Issue 11 , Pages 1249-1255, November 2009